Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical Performance of Two SARS-CoV-2 Serologic Assays
Mei San Tang, Karl Hock, Nicole M Logsdon, et al.
Clinical Chemistry (2020) Vol. 66, Iss. 8, pp. 1055-1062
Open Access | Times Cited: 204

Showing 1-25 of 204 citing articles:

Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with a High Attack Rate
Amin Addetia, Katharine H. D. Crawford, Adam S. Dingens, et al.
Journal of Clinical Microbiology (2020) Vol. 58, Iss. 11
Open Access | Times Cited: 575
Testing for SARS-CoV-2 (COVID-19): a systematic review and clinical guide to molecular and serological in-vitro diagnostic assays
Antonio La Marca, Martina Capuzzo, Tiziana Paglia, et al.
Reproductive BioMedicine Online (2020) Vol. 41, Iss. 3, pp. 483-499
Open Access | Times Cited: 397
Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison
Mark Ainsworth, Monique Andersson, Kathryn Auckland, et al.
The Lancet Infectious Diseases (2020) Vol. 20, Iss. 12, pp. 1390-1400
Open Access | Times Cited: 384
Testing at scale during the COVID-19 pandemic
Tim R. Mercer, Marc Salit
Nature Reviews Genetics (2021) Vol. 22, Iss. 7, pp. 415-426
Open Access | Times Cited: 353
Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech)
T. NICOL, Caroline Lefeuvre, Orianne Serri, et al.
Journal of Clinical Virology (2020) Vol. 129, pp. 104511-104511
Open Access | Times Cited: 227
COVID-19 Antibody Tests and Their Limitations
Guoqiang Liu, James F. Rusling
ACS Sensors (2021) Vol. 6, Iss. 3, pp. 593-612
Closed Access | Times Cited: 199
Performance Characteristics of Four High-Throughput Immunoassays for Detection of IgG Antibodies against SARS-CoV-2
Elitza S. Theel, Julie Harring, Heather Hilgart, et al.
Journal of Clinical Microbiology (2020) Vol. 58, Iss. 8
Open Access | Times Cited: 196
Antibody tests for identification of current and past infection with SARS-CoV-2
Tilly Fox, Julia Geppert, Jacqueline Dinnes, et al.
Cochrane library (2022) Vol. 2022, Iss. 11
Open Access | Times Cited: 177
Development and Validation of the Elecsys Anti-SARS-CoV-2 Immunoassay as a Highly Specific Tool for Determining Past Exposure to SARS-CoV-2
Peter Muench, Simon Jochum, Verena Wenderoth, et al.
Journal of Clinical Microbiology (2020) Vol. 58, Iss. 10
Open Access | Times Cited: 168
Quantification of SARS-CoV-2 antibodies with eight commercially available immunoassays
Lisa Weidner, Simon Gänsdorfer, Stephan Unterweger, et al.
Journal of Clinical Virology (2020) Vol. 129, pp. 104540-104540
Open Access | Times Cited: 151
Serodiagnostics for Severe Acute Respiratory Syndrome–Related Coronavirus 2
Matthew P. Cheng, Cédric P. Yansouni, Nicole E. Basta, et al.
Annals of Internal Medicine (2020) Vol. 173, Iss. 6, pp. 450-460
Open Access | Times Cited: 146
Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Serologic Testing
Mary K. Hayden, Ibrahim K El Mikati, Kimberly E. Hanson, et al.
Clinical Infectious Diseases (2024)
Open Access | Times Cited: 62
Side-by-Side Comparison of Three Fully Automated SARS-CoV-2 Antibody Assays with a Focus on Specificity
Thomas Perkmann, Nicole Perkmann‐Nagele, Marie‐Kathrin Breyer, et al.
Clinical Chemistry (2020) Vol. 66, Iss. 11, pp. 1405-1413
Open Access | Times Cited: 132
Association between SARS-CoV-2 Neutralizing Antibodies and Commercial Serological Assays
Mei San Tang, James Brett Case, Caroline E Franks, et al.
Clinical Chemistry (2020) Vol. 66, Iss. 12, pp. 1538-1547
Open Access | Times Cited: 127
Clinical evaluation of serological IgG antibody response on the Abbott Architect for established SARS-CoV-2 infection
Ka Lip Chew, Shaun Shi Yan Tan, Sharon Saw, et al.
Clinical Microbiology and Infection (2020) Vol. 26, Iss. 9, pp. 1256.e9-1256.e11
Open Access | Times Cited: 122
Prevalence of Sars-Cov-2 Infection in Health Workers (HWs) and Diagnostic Test Performance: The Experience of a Teaching Hospital in Central Italy
Edith Lahner, Emanuele Dilaghi, Claudio Prestigiacomo, et al.
International Journal of Environmental Research and Public Health (2020) Vol. 17, Iss. 12, pp. 4417-4417
Open Access | Times Cited: 117
Quantification of antibody avidities and accurate detection of SARS-CoV-2 antibodies in serum and saliva on plasmonic substrates
Tiancheng Liu, Jessica Hsiung, Su Zhao, et al.
Nature Biomedical Engineering (2020) Vol. 4, Iss. 12, pp. 1188-1196
Open Access | Times Cited: 95
Characterization of SARS-CoV-2 nucleocapsid protein reveals multiple functional consequences of the C-terminal domain
Chao Wu, Abraham J. Qavi, Asmaa Hachim, et al.
iScience (2021) Vol. 24, Iss. 6, pp. 102681-102681
Open Access | Times Cited: 92
Longitudinal characterization of the IgM and IgG humoral response in symptomatic COVID-19 patients using the Abbott Architect
Gabriel N. Maine, Kriselle Maris Lao, Subhashree Mallika Krishnan, et al.
Journal of Clinical Virology (2020) Vol. 133, pp. 104663-104663
Open Access | Times Cited: 90
Comparison of the diagnostic sensitivity of SARS-CoV-2 nucleoprotein and glycoprotein-based antibody tests
Carolin Schnurra, Nina Reiners, Ronald Biemann, et al.
Journal of Clinical Virology (2020) Vol. 129, pp. 104544-104544
Open Access | Times Cited: 80
Antibody responses to SARS-CoV-2 in patients with differing severities of coronavirus disease 2019
Ekasit Kowitdamrong, Thanyawee Puthanakit, Watsamon Jantarabenjakul, et al.
PLoS ONE (2020) Vol. 15, Iss. 10, pp. e0240502-e0240502
Open Access | Times Cited: 79
Clinical and Laboratory Diagnosis of SARS-CoV-2, the Virus Causing COVID-19
Severino Jefferson Ribeiro da Silva, Caroline Targino Alves da Silva, Klarissa Miranda Guarines, et al.
ACS Infectious Diseases (2020) Vol. 6, Iss. 9, pp. 2319-2336
Open Access | Times Cited: 78
Clinical Performance of the Roche SARS-CoV-2 Serologic Assay
Mei San Tang, Karl Hock, Nicole M Logsdon, et al.
Clinical Chemistry (2020) Vol. 66, Iss. 8, pp. 1107-1109
Open Access | Times Cited: 73
Compassionate use of convalescent plasma for treatment of moderate and severe pneumonia in COVID-19 patients and association with IgG antibody levels in donated plasma
‪Yasmin Maor‬‏, Dani Cohen, Nir Paran, et al.
EClinicalMedicine (2020) Vol. 26, pp. 100525-100525
Open Access | Times Cited: 69
A novel highly quantitative and reproducible assay for the detection of anti-SARS-CoV-2 IgG and IgM antibodies
Kenta Noda, Kouki Matsuda, Shigehiro Yagishita, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 66
Page 1 - Next Page

Scroll to top